Wednesday, November 25, 2009, 10:40am EST - Canadian Markets close in 5 hours and 20 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Nektar Therapeutics (NKTR)

At 10:24 EST: 8.91 USD  Up 0.21 (2.41%)  
MORE ON NKTR
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Sep-07 30-Jun-07 31-Mar-07 31-Dec-06
Total Revenue 56,321   65,917   85,016   69,904  
Cost of Revenue 27,457   39,490   56,522   41,142  
Gross Profit 28,864   26,427   28,494   28,762  
Operating Expenses
Research Development 35,773   41,000   37,492   41,365  
Selling General and Administrative 12,426   13,178   16,735   17,441  
Non Recurring -   -   -   9,410  
Others 237   237   236   708  
Total Operating Expenses -   -   -   68,924  
Operating Income or Loss (19,572) (27,988) (25,969) (40,162)
Income from Continuing Operations
Total Other Income/Expenses Net 5,724   5,430   5,479   7,056  
Earnings Before Interest And Taxes (13,848) (22,558) (20,490) (33,106)
Interest Expense 4,773   4,702   4,933   4,921  
Income Before Tax (18,621) (27,260) (25,423) (38,027)
Income Tax Expense -   250   250   828  
Minority Interest -   -   -   -  
Net Income From Continuing Ops (18,621) (27,510) (25,673) (38,855)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (18,621) (27,510) (25,673) (38,855)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares ($18,621) ($27,510) ($25,673) ($38,855)

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol:
Symbol Lookup
Latest News Canadian Indices


Reuters offers more in-depth Company Research , Stock Screening , and Risk Alerts on over 10,000 U.S. Equities.